Psychotropics and sexual dysfunction: The evidence and treatments

Advances in Psychosomatic Medicine

Volumn 29, Issue , 2008, Pages 107-130

  Labbate, L ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; NEUROLEPTIC AGENT; TRANQUILIZER;

CHEMICALLY INDUCED DISORDER; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; EJACULATION; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; LIBIDO; MALE; MENTAL DISEASE; ORGASM; PSYCHOSEXUAL DISORDER; REVIEW; SEXUAL DYSFUNCTION;

ANTICONVULSANTS; ANTIPSYCHOTIC AGENTS; CONTROLLED CLINICAL TRIALS AS TOPIC; EJACULATION; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; LIBIDO; MALE; MENTAL DISORDERS; ORGASM; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; TRANQUILIZING AGENTS;

EID: 46449115654     PISSN: 00653268     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000126627     Document Type: Review

References (39)

1. Casper RC, Redmond DE Jr, Katz MM, Schaffer CB, Davis JM, Koslow SH: Somatic symptoms in primary affective disorder. Presence and relationship to the classification of depression. Arch Gen Psychiatry 1985;42:1098-1104.
2. Montejo-González AL, Llorca G, Izquierdo JA, Ledesma A, Bousoño M, Calcedo A, Carrasco JL, Ciudad J, Daniel E, De la Gandara J, Derecho J, Franco M, Gomez MJ, Macias JA, Martin T, Perez V, Sanchez JM, Sanchez S, Vicens EJ: SSSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. Sex Marital Ther 1997;23:176-194.
3. Landén M, Högberg P: Thase ME: Incidence of sexual side effects in refractory depression during treatment with citalopram or paroxetine.J Clin Psychiatry 2005;66:100-106.
4. Nicolosi A, Laumann EO, Glasser DB, Moreira ED Jr, Paik A, Gingell C: Global Study of Sexual Attitudes and Behaviors Investigators' Group: Sexual behavior and sexual dysfunctions after age 40: the global study of sexual attitudes and behaviors. Urol 2004;64:991-997.
5. Thase ME, Clayton AH, Haight BR, Thompson AH, Modell JG, Johnston JA: A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability. J Clin Psychopharmacol 2006;26:482-488.
6. Behnke K, Søgaard J, Martin S, Bäuml J, Ravindran AV, Agren H, Vester-Blokland ED: Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study. J Clin Psychopharmacol 2003;23:358-364.
7. Coleman CC, King BR, Bolden-Watson C, Book MJ, Segraves RT, Richard N, Ascher J, Batey S, Jamerson B, Metz A: A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine. Clin Ther 2001;23:1040-1058.
8. Segraves RT, Kavoussi R, Hughes AR, Batey SR, Johnston JA, Donahue R, Ascher JA: Evaluation of sexual functioning in depressed outpatients: a double-blind comparison of sustained-release bupropion and sertraline treatment. J Clin Psychopharmacol 2000;20:122-128.
9. Clayton AH, Zajecka J, Ferguson JM, Filipiak-Reisner JK, Brown MT, Schwartz GE: Lack of sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive disorder. Int Clin Psychopharmacol 2003;18:151-156.
10. Delgado PL, Brannan SK, Mallinckrodt CH, Tran PV, McNamara RK, Wang F, Watkin JG, Detke MJ: Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder. J Clin Psychiatry 2005;66:686-692.
11. Montejo AL, Llorca G, Izquierdo JA, Rico-Villademoros F: Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction: Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. J Clin Psychiatry 2001;62(suppl 3):10-21.
12. Waldinger MD, Zwinderman AH, Olivier B: Antidepressants and ejaculation: a double-blind, randomized, fixed-dose study with mirtazapine and paroxetine. J Clin Psychopharmacol 2003;23:467-470.
13. Gelenberg AJ, McGahuey C, Laukes C, Okayli G, Moreno F, Zentner L, Delgado P: Mirtazapine substitution in SSSRI-induced sexual dysfunction. J Clin Psychiatry 2000;61:356-360.
14. Ferguson JM, Shrivastava RK, Stahl SM, Hartford JT, Borian F, Ieni J, McQuade RD, Jody DJ: Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline. Clin Psychiatry 2001;62:24-29.
15. Labbate LA, Grimes JB, Hines A, Pollack MH: Bupropion treatment of serotonin reuptake antidepressant-associated sexual dysfunction. Ann Clin Psychiatry 1997;9:241-245.
16. Clayton AH, Warnock JK, Kornstein SG, Pinkerton R, Sheldon-Keller A, McGarvey EL: A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry 2004;65:62-67.
17. Landén M, Eriksson E, Agren H, Fahlén T: Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors. J Clin Psychopharmacol 1999;19:268-271.
18. Seidman SN, Roose SP, Menza MA, Shabsigh R, Rosen RC: Treatment of erectile dysfunction in men with depressive symptoms: results of a placebo-controlled trial with sildenafil citrate. Am J Psychiatry 2001;158:1623-1630.
19. Fava M, Nurnberg HG, Seidman SN, Holloway W, Nicholas S, Tseng LJ, Stecher VJ: Efficacy and safety of sildenafil in men with serotonergic antidepressant-associated erectile dysfunction: results from a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 2006;67:240-246.
20. Nurnberg HG, Hensley PL, Gelenberg AJ, Fava M, Lauriello J, Paine S: Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial. JAMA 2003;289:56-64.
21. Dossenbach M, Hodge A, Anders M, Molnár B, Peciukaitiene D, Krupka-Matuszczyk I, Tatu M, Bondar V, Pecenak J, Gorjanc T, McBride M: Prevalence of sexual dysfunction in patients with schizophrenia: international variation and underestimation. Int J Neuropsychopharmacol 2005;8:195-201.
22. Kelly DL, Conley RR: A randomized double-blind 12-week study of quetiapine, risperidone or fluphenazine on sexual functioning in people with schizophrenia. Psychoneuroendocrinology 2006;31:340-346.
23. Knegtering H, Boks M, Blijd C, Castelein S, van den Bosch RJ, Wiersma D: A randomized open-label comparison of the impact of olanzapine versus risperidone on sexual functioning. J Sex Marital Ther 2006;32:315-326.
24. Nakonezny PA, Byerly MJ, Rush AJ: The relationship between serum prolactin level and sexual functioning among male outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind trial of risperidone vs. quetiapine. J Sex Marital Ther 2007;33:203-216.
25. Bobes J, Garc A-Portilla MP, Rejas J, Hern Ndez G, Garcia-Garcia M, Rico-Villademoros F, Porras A: Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study. J Sex Marital Ther 2003;29:125-147.
26. Uçok A, Incesu C, Aker T, Erkoç S: Sexual dysfunction in patients with schizophrenia on antipsychotic medication. Eur Psychiatry 2007;22:328-333.
27. Byerly MJ, Nakonezny PA, Bettcher BM, Carmody T, Fisher R, Rush AJ: Sexual dysfunction associated with second-generation antipsychotics in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of olanzapine, risperidone, and quetiapine. Schizophr Res 2006;86:244-250.
28. Dossenbach M, Dyachkova Y, Pirildar S, Anders M, Khalil A, Araszkiewicz A, Shakhnovich T, Akram A, Pecenak J, McBride M, Treuer T: Effects of atypical and typical antipsychotic treatments on sexual function in patients with schizophrenia: 12-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study. Eur Psychiatry 2006;21:251-258.
29. Bitter I, Basson BR, Dossenbach MR: Antipsychotic treatment and sexual functioning in first-time neuroleptic-treated schizophrenic patients. Int Clin Psychopharmacol 2005;20:19-21.
30. Perlis RH, Baker RW, Zarate CA Jr, Brown EB, Schuh LM, Jamal HH, Tohen M: Olanzapine versus risperidone in the treatment of manic or mixed States in bipolar I disorder: a randomized, double-blind trial. J Clin Psychiatry 2006;67:1747-1753.
31. Hummer M, Kemmler G, Kurz M, Kurzthaler I, Oberbauer H, Fleischhacker WW: Sexual disturbances during clozapine and haloperidol treatment for schizophrenia. Am J Psychiatry 1999;156:631-633.
32. Gopalakrishnan R, Jacob KS, Kuruvilla A, Vasantharaj B, John JK: Sildenafil in the treatment of antipsychotic-induced erectile dysfunction: a randomized, double-blind, placebo-controlled, flexible-dose, two-way crossover trial. Am J Psychiatry 2006;163:494-499.
33. Aizenberg D, Sigler M, Zemishlany Z, Weizman A: Lithium and male sexual function in affective patients. Clin Neuropharmacol 1996;19:515-519.
34. Ghadirian AM, Annable L, Bélanger MC: Lithium, benzodiazepines, and sexual function in bipolar patients. Am J Psychiatry 1992;149:801-805.
35. Zuncheddu C, Carpiniello B: Sexual dysfunctions and bipolar disorder: a study of patients submitted to a long- term lithium treatment Clin Ter 2006;157:419-424.
36. Gil-Nagel A, López-Muñoz F, Serratosa JM, Moncada I, García-García P, Alamo C: Effect of lamotrigine on sexual function in patients with epilepsy Seizure 2006;15:142-149.
37. Schneck CD, Thomas MR, Gundersen D: Sexual side effects associated with valproate. J Clin Psychopharmacol 2002;22:532-534.
38. Herzog AG, Drislane FW, Schomer DL, Pennell PB, Bromfield EB, Dworetzky BA, Farina EL, Frye CA: Differential effects of antiepileptic drugs on sexual function and hormones in men with epilepsy. Neurology 2005 11;65:980-981.
39. Dasberg HH: Effects and plasma levels of N-desmethyldiazepam after oral administration in normal volunteers. Psychopharmacologia 1975;43:191-198.